Pembrolizumab for Advanced NSCLC and PS 2-3

Clinical trial NCT05589818 · RECRUITING

Trial details

NCT number: NCT05589818
Sponsor: Icahn School of Medicine at Mount Sinai
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer (NSCLC)

Start date: 2023-12-05
Primary completion: 2027-05-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.